Latest Hydromorphone Stories
A Swedish researcher says drugs that may cause dose dumping, releasing medication in an unsafe manner in those who have drunk alcohol, need to be tested. Hans Lennernas, a professor in Biopharmaceutics at Uppsala University in Sweden, says some controlled release pills and capsules are susceptible to dose dumping. Lennernas says a formulation of the pain medication hydromorphone is one example of dose dumping.
Controlled release pills and capsules that show a tendency in the standard laboratory test toward "dose dumping" â€” releasing their medicine in a faster and potentially unsafe manner in patients who have consumed alcohol â€” should be withheld from the market until proven safe with testing in people.
BRISTOL, Tenn., Aug. 13 /PRNewswire-FirstCall/ -- King Pharmaceuticals((R)), Inc. (NYSE: KG) today announced that the U.S.
CONSHOHOCKEN, PA and VANCOUVER, BC, June 17 /PRNewswire/ - Neuromed Pharmaceuticals Ltd. announced today that its subsidiary Neuromed Development Inc., has sold the U.S.
CUPERTINO, Calif., June 16 /PRNewswire-FirstCall/ -- DURECT Corporation (Nasdaq: DRRX) announced today that Dr. Joseph Stauffer has joined DURECT as Chief Medical Officer and Executive Vice President, Corporate Strategy. (Logo: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO) "Dr.
CONSHOHOCKEN, PA and VANCOUVER, BC, June 11 /PRNewswire/ - Neuromed Pharmaceuticals Ltd. announced today that it has received notification that Merck & Co., Inc.
A coroner in Las Vegas has ruled impressionist Danny Gans died accidentally of heart failure brought on by a toxic level of the pain killer hydromorphone. Clark County Coroner Mike Murphy would not characterize the May 1 death of the 52-year-old performer as a drug overdose, The New York Times reported Thursday.
- Oxycodone Successfully Delivered into the Bloodstream - Data Demonstrates Sustained Release and Increased Blood Levels of Oxycodone MELBOURNE, Australia, May 29 /PRNewswire-FirstCall/ -- Phosphagenics Limited ("Phosphagenics") (ASX: POH; OTCQX: PPGNY) today announced the successful completion of preclinical studies related to its patented TPM/oxycodone transdermal patch system.
BETHESDA, Md., May 26 /PRNewswire/ -- On May 27 and 28, 2009, the Food and Drug Administration (FDA) will hear testimony about the FDA-guided effort to develop a classwide Risk Evaluation and Mitigation Strategy (REMS) for all controlled-release opioids from more than 70 patients, scientists, public health professionals, and representatives of pharmacist groups, prescriber groups, and pharmaceutical companies.
Oh Thursday, the Food and Drug Administration reversed its initial plan to remove unapproved liquid morphine from being sold in the US.
- The act of sweetening by admixture of some saccharine substance.